|

Placebo Fecal microbiota transfer Clinical Trials

1 actively recruiting trial

Also known as: Placebo FMT, Placebo INTESTIFIX 001

Pipeline

Phase 2: 1

Top Sponsors

  • Michael Dill1

Indications

  • Liver Disease1
  • HCC - Hepatocellular Carcinoma1
  • Immunotherapy1
  • Liver Cancer1
  • Cancer1

Other1 trial

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.